Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
2(14%)
Results Posted
20%(2 trials)

Phase Distribution

Ph phase_2
1
7%
Ph phase_1
11
79%
Ph phase_3
1
7%

Phase Distribution

11

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
11(84.6%)
Phase 2Efficacy & side effects
1(7.7%)
Phase 3Large-scale testing
1(7.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(10)
Terminated(1)
Other(1)

Detailed Status

Completed10
Active, not recruiting1
Recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 111 (84.6%)
Phase 21 (7.7%)
Phase 31 (7.7%)

Trials by Status

active_not_recruiting17%
recruiting17%
completed1071%
unknown17%
withdrawn17%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT04380753Phase 1

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

Completed
NCT05118854Phase 2

A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation

Recruiting
NCT04303780Phase 3

Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Active Not Recruiting
NCT04667234

Expanded Access of Sotorasib

Unknown
NCT05598281Phase 1

Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants

Completed
NCT05581992Phase 1

Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Completed
NCT05577624Phase 1

A Study to Evaluate the Drug-drug Interaction Effect of Rifampin on the Pharmacokinetics of AMG 510 in Healthy Participants

Completed
NCT05581758Phase 1

A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Completed
NCT05550129Phase 1

Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants

Completed
NCT05568082Phase 1

A Study to Evaluate the Drug-drug Interaction Effect of Itraconazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Completed
NCT05599828Phase 1

A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

Completed
NCT05180422Phase 1

A Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis

Withdrawn
NCT05578859Phase 1

A Study of the Absorption, Metabolism, and Excretion of [14C]-AMG 510 Following a Single Oral Dose in Healthy Male Subjects

Completed
NCT05571163Phase 1

A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy Participants

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14